Indivior's opioid addiction sprat approved by FDA
By Frank Prenesti
Date: Tuesday 23 May 2023
(Sharecast News) - US health regulators have approved Indivior's Opvee nasal spray treatment for opiod addiction, the company said on Tuesday.
The drug will help combat overdoses caused by fentanyl and other opioids dtiving America's drug crisis. Opvee works by blocking the effects of opioids in the brain, which can restore breathing and blood pressure in people who have recently overdosed.
"Opvee's Food and Drug Administration's approval represents a significant achievement in the development of new treatment options to address today's era of opioid overdoses that are driven by powerful synthetic opioids, such as fentanyl," said chief executive Mark Crossley.
Reporting by Frank Prenesti for Sharecast.com
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN